Navigation Links
Asymchem Laboratories Hires Three New Employees: Guojie Xu, Pingzhong Huang, and Xiaojun Huang
Date:4/23/2010

MORRISVILLE, N.C., April 23 /PRNewswire/ -- Asymchem Laboratories is proud to announce and welcome Dr. Guojie (George) Xu as Director of Formulation Development, Dr. Pingzhong Huang as Director of Chemical Development, and Dr. Xiaojun Huang as Senior Director of Chemical Development.

Dr. Guojie (George) Xu joined Asymchem on February 1, 2010.  He brings extensive scientific and managerial experience in pharmaceutical formulations to Asymchem.    Dr. Xu was most recently Product Development Manager at Sandoz, where he held roles of increasing responsibility over 10 year.  Educated in China, he went on to earn a Ph.D. in Pharmaceutics from Meijo University in Japan and held appointments at Shenyang Pharmaceutical University, Beijing Institute for Pharmacology & Toxicology, and the University of Chicago.  Dr. Xu splits his time between Asymchem's Morrisville, NC headquarters and Life Science Center in Tianjin, China.

Dr. Pingzhong Huang joined Asymchem on March 15, 2010.  He brings 15 years of experience in contract synthesis and pharmaceutical process chemistry to the job, most recently at Wyeth in Pearl River, New York where he was a Senior Research Scientist in the Chemical Sciences group.  Dr. Huang graduated from Peking University and earned a Ph.D. in synthetic organic chemistry at the University of Geneva.  Dr. Huang splits his time between Asymchem's Morrisville, NC headquarters and Life Science Center in Tianjin, China.

Dr. Xiaojun Huang will be joining Asymchem on April 26, 2010.  Dr. Huang has previous experience at Roche, where he was a research scientist in Palo Alto, California, and Pfizer in La Jolla, California.  He has degrees in chemistry from Fudan University in Shanghai and the University of Edmonton and also held a postdoctoral appointment at Stanford University with Barry Trost. Dr. Huang will be based at Asymchem's Life Science Center in Tianjin, China.

Asymchem Laboratories is a leading research-based contract manufacturer specializing in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API's and Drug Products serving the pharmaceutical industry. With a 15 yr track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena.  For further information, please visit the Asymchem website at www.asymchem.com or contact Leigh-Anne Ronk at 919-468-3884.

               


'/>"/>
SOURCE Asymchem Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Three Steps to Boost Asymchems Investment in China
2. Pfizer Global R&D Presents 2008 Top Intermediates CMO Award to Asymchem
3. Dr. Chris Huber Joins Asymchem Laboratories Inc. as Director of Chemical Development
4. Codexis Appoints Singapore Laboratories Managing Director
5. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
6. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
7. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
8. Stiefel Laboratories Appoints Two New Members to Board of Directors
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
10. ARUP Laboratories Releases ARUP Consult(R) 2.0
11. Forest Laboratories Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , ... February 10, 2016 , ... ... the International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st Annual Vendor ... expecting to fill more than 100 tables for its annual event, which will ...
(Date:2/10/2016)... ... February 10, 2016 , ... PatientCrossroads announces ... the secure online PatientCrossroads platform, has exceeded both its one-year and overall recruitment ... PROMPT study, which seeks to advance understanding of the hereditary risks for certain ...
(Date:2/10/2016)... ... February 10, 2016 , ... Cenna Bioscience Inc., an ... treatment of Alzheimer’s disease, announced today it has been selected to present at the ... Breakers in Palm Beach, Florida. The purpose of the Forum is to help ...
(Date:2/9/2016)... 9, 2016  Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies ... organs, recently reported the Company,s operating results for ... 2016. Lonza America , Inc. (the ... year in the process of consummating an agreement ...
Breaking Biology Technology:
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
(Date:2/1/2016)... -- Today, the first day of American Heart Month, the ... first of its kind workplace health solution that leverages ... first application of Watson to ... Welltok will create a new offering that combines AHA,s ... on Welltok,s health optimization platform. The effort is intended ...
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the ... pharma and publication industries, will provide the data management ... Centre (NPSC). ... Phenotypic analysis measures ... whole organisms, allowing comparisons between states such as health ...
Breaking Biology News(10 mins):